TrialStem cells translational medicine2021

Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.

Pawan Kumar Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.